Two Common Lung Treatments Fail to Help Children

A 424-child international trial found prone positioning and HFOV did not shorten time on ventilators for pediatric ARDS.

Updated on Nov. 6, 2026 in Children’s Health

Isometric editorial illustration of a coiled ventilator hose and a matte oscillator unit beside an empty bed in a bare intensive care bay.
A large international trial found that routine early prone positioning and high-frequency ventilation did not shorten time on ventilators for children with pediatric ARDS. AI Illustration. Upload story photo >

A large international trial found that routine early use of prone positioning or high-frequency oscillatory ventilation (HFOV) did not increase ventilator-free days for children with pediatric acute respiratory distress syndrome (ARDS). The results, published in The Lancet, suggest these approaches should not be routine first-line treatment for children in intensive care.

Why it matters

Pediatric ARDS is a life-threatening lung condition requiring intensive support, and these two techniques have been widely used as standard first-line options. Showing they do not improve time off a ventilator, and may carry added risks, gives clinicians and families clearer evidence to guide care decisions in pediatric intensive care units.

This phase 3 randomised controlled trial enrolled 424 children across 75 hospitals in 18 countries and compared each intervention against usual care. Neither prone positioning nor HFOV increased ventilator-free days through day 28, and 28-day mortality was 10% with no significant differences between groups.

The players

Children's Hospital of Philadelphia

A major pediatric medical center whose researchers served as lead senior authors on the PROSpect trial.

University of Pennsylvania

A leading research university whose School of Nursing contributed to the PROSpect trial.

The details

Prone positioning turns the child onto the stomach to help improve oxygen delivery to the lungs, while HFOV uses rapid, small pressure oscillations to keep the lungs open with minimal large breaths. In this trial, prone positioning was associated with more airway obstruction and pressure-related skin injuries, and HFOV was linked to increased hemodynamic instability. The researchers concluded that these added risks were not offset by any benefit in getting children off ventilators sooner.

Timeline

  1. Results of the PROSpect trial were reported in the news on November 6, 2026.

Health Landscape

Prone positioning and HFOV have been used as standard first-line tools in pediatric intensive care for children with ARDS. The PROSpect trial's null findings challenge routine first-line use and point toward de-implementing these approaches in favor of more targeted care.

If your child has been hospitalized with severe breathing difficulty, it is worth asking the care team which treatment approaches they are using and why. Families should discuss these findings with their child's pediatric critical care physician to understand how they apply to their child's situation.

The takeaway

The PROSpect trial suggests routine early prone positioning and HFOV may not be the best first-line choice for pediatric ARDS, since they did not shorten time on a ventilator. Families and clinicians can ask care teams which evidence-based approaches are being used and discuss the trial's findings with a pediatric critical care specialist.

Further reading

For broader context on treatment approaches for young patients, explore our Children's Health coverage.

More information

Read the original PROSpect trial in The Lancet for the full study design and results.

Source note: This article includes information reported by News-Medical.